CFG
AZN icon

Carter Financial Group’s AstraZeneca AZN Stock Holding History

Carter Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,104
Closed -$218K – 137
2026
Q1 		$218K Sell
1,104
-709
-39% -$137K 0.13% 108
2025
Q4 		$333K Buy
1,813
+406
+29% +$71.2K 0.2% 86
2025
Q3 		$216K Sell
1,407
-193
-12% -$29.2K 0.13% 108
2025
Q2 		$224K Buy
+1,600
New +$224K 0.15% 98

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Carter Financial Group's AZN Position: Q2 2026 in Review

Carter Financial Group sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,104 shares — an estimated $218K sold.

Carter Financial Group first reported a position in AZN in Q2 2025 and held it in 4 quarters. The position peaked at $333K in Q4 2025. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Carter Financial Group reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Carter Financial Group sold 1,104 AstraZeneca shares in Q2 2026, an estimated $218K.
  • Carter Financial Group first reported a position in AstraZeneca in Q2 2025 and held it in 4 quarters.
  • Carter Financial Group's AstraZeneca position peaked at $333K in Q4 2025.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Carter Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.